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ABSTRACT
Objectives: The Clinical Research Training Fellowship
(CRTF) allows up to 3 years support for clinically
qualified candidates to undertake specialised or further
research training in biomedical sciences. CRTFs are
perceived as a crucial step in the career development
and progression of Clinical Academics but there are no
published data to support this notion. We conducted
an electronic survey of a large cohort of Medical
Research Council (MRC) CRTFs followed for up to
20 years.
Design: Retrospective analysis of CRTF outcome data
held with the MRC, UK.
Participants: Two cohorts comprising 40 CRFTs
awarded by the MRC in the year 1991 and 299 MRC
CRTFs who were awarded a fellowship between 1993
and 2003.
Results: The MRC CRTF scheme built capacity in
clinical academia across the UK with 40% of CRTFs
progressing to a University professorship. Importantly,
the CRTF scheme is also providing NHS consultants
who remain research active.
Conclusions: This is the first analysis of outcome of
CRTFs in the UK and provides robust evidence of the
importance of this capacity building mode of funding
to underpin research excellence at the University–NHS
interface.
INTRODUCTION
The Clinical Research Training Fellowship
(CRTF) allows up to 3 years support for a
clinically qualiﬁed candidate to undertake a
specialised or further research training in
biomedical sciences with the aim of attaining
a higher degree such as a PhD or in some
cases an MD. In the UK alone over 350 such
posts exist in any given year, funded by a
variety of organisations including the
Medical Research Council (MRC), the
Wellcome Trust, British Heart Foundation,
Cancer Research UK, Arthritis Research UK
and National Institute of Health Research
and devolved administrations.1 The percep-
tion has been that these form a crucial step
in the career development and progression
of Clinical Academics, supporting a dedi-
cated period of postgraduate research train-
ing. Although ongoing clinical training is
encouraged during the CRTF it is capped at
10–20% of total activity and in the UK is
recognised as part of the Modernising
Medical Careers pathway (http://www.mmc.
nhs.uk).
The investment in this scheme from the
government through the MRC and from the
charity sector is signiﬁcant, yet there are no
long-term data on outcomes of the added
value that this funding provides. Because a
relatively low proportion of these fellowships
convert to postdoctoral research training pro-
grammes (the Clinician Scientist scheme),
the overall quality of candidates and value of
the scheme has been called into question.
The MRC scheme has been in operation
for over 30 years and today oversees approxi-
mately 50–55 new awards/year across all dis-
ciplines of Medicine. Many individual CRTFs
are cofunded by the MRC and a charity or
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other partner (some 21 organisations in 2011), extend-
ing the reach of the scheme. We have performed an
analysis of outcome of a large cohort of MRC CRTFs.
METHODS
This study had two components. The ﬁrst involved 40
clinical training fellowships that were awarded by the
MRC in the year 1991. The current employment of
these individuals was ascertained by one researcher
(PHM, who held one of the CRTFs awarded in 1991)
utilising information in the public domain, speciﬁcally
the Medical Directory, the Medical Register, Pubmed,
Doctors.net, professional societies and Google. In all
cases it was possible to identify the individuals unam-
biguously. The second outcome involved 299 CRTFs who
were awarded a fellowship between 1993 and 2003. The
internet was the main tool for identifying current
contact details/email addresses through search engines,
institutional, publication and professional websites.
The online survey comprised 15 questions that aimed
to obtain information on the CRTFs current professional
role, the proportion of current time spent on clinical
and research activity, research interests and clinical spe-
cialty, involvement in leadership, administrative and
teaching duties, outcome of CRTF, further funding
secured and a personal assessment as to the overall
impact of the CRTF on their career (see supplementary
information for survey details).
RESULTS
The current positions of the 1991 cohort are sum-
marised in ﬁgure 1. Typically these individuals (who are
now approximately 50 years of age) undertook a PhD
followed by completion of specialised training. The
cohort includes current Professors of Medicine and
medical disciplines across many UK-based Universities
and beyond. Eight (20%) have been elected as Fellows
of the Academy of Medical Sciences in recognition of
their outstanding contributions to medical science.
Of the 299 individuals in the second cohort, in 31
cases email addresses either bounced back or did not
match the CRTF individual to which they were assigned.
Through this approach 191 individuals responded to a
simple questionnaire, giving a 71% response rate. The
responses were submitted anonymously, so no informa-
tion was obtained about non-responders. However, in
299 CRTF email addresses, only 18 (6%) were not aca-
demic or NHS related, so it is reasonable to assume that
a large proportion of the non responders were still
engaged in University and/or NHS/research and clin-
ical activity.
Of the 191 responding CRTFs, over 90% were cur-
rently based within a University or University Teaching
Hospital (ﬁgure 2). Forty-six (24%) were Professors, 16
Readers (8%) and 53 (28%) Senior Clinical Lecturers
(28%). Fifty-one (27%) were NHS Consultants and the
remainder still in career grades (Clinical Fellows and
Clinical Lecturers). About 1% of the cohort was industry
based. Not surprisingly, this proﬁle differed across year
of intake to the CRTF; when the ﬁrst intake—the class
of 1993—was speciﬁcally analysed 38% were Professors,
4% Readers and 37% NHS consultants, in keeping with
the analysis of the 1991 cohort. It is highly likely there-
fore that 1991 and 1993 are representative years in ana-
lysing the long-term outcome of CRTFs.
Of the 51 self-declared ‘NHS consultants’, 41 (80%)
described themselves as being research active, spending
a median of 25% of their time on research. Conversely
88% of University only contracted staff were clinically
active, spending a median of 50% of their time on clin-
ical work. Engagement in research did differ between
CRTFs holding academic or NHS positions; the former
were predominantly leading research activity (95%) as
well as contributing to that of others, while NHS staff
were more likely to contribute to activity of others
(52%) rather than lead themselves (12%). A total of
58% of all ex-CRTFs were also involved in activities
underpinning research administration such as commis-
sioning, research panels, funding allocation and/or
research regulation. Finally 98% of the cohorts were
involved in education, with an equal split in participa-
tion (all in excess of 85%) in the supervision of students,
lecturing and clinical teaching.
The top 10 commonest medical disciplines of the
CRTFs were gastroenterology (21), neurology (18),
nephrology (14), diabetes and endocrinology (12), thor-
acic medicine (11), mental illness (10), cardiology (9)
rheumatology (9), infectious diseases (7) and haematol-
ogy, paediatrics and general surgery (each 5). The pre-
dominant research area engaged by the CRTFs was
self-reported to be biomedical/experimental in 43% of
cases, clinical trials in 27%, applied health research in
10% and pharmaceutical industry research in 5%.
In total 171 of 191 individuals (90%) obtained a PhD
and of these 75% did so within a 3-year period from the
Figure 1 The current status of the 1991 Clinical Research
Training Fellowship cohort (n=40).
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date of the CRTF award. Twelve individuals obtained an
MD degree and two an MSc. 1 subject had a PhD on
starting the CRTF. Three participants did not obtain a
higher degree and two did not answer.
A total of 63% of fellows told us about future grant
funding from a wide range of funders; in 82% of the
cases this supported further postdoctoral training with
23 fellows progressing to successful clinician scientist
posts at the time of the questionnaire. Only 52% had
secured a 3-year project grant and 13% a 5-year pro-
gramme grant. In a separate analysis, 224 CRTFs at
various stages of their award submitted data via MRC
e-Val. About 35% report obtaining further funding from
2006/2007 to 2009/2010. The data showed how this
cohort is also beneﬁtting from a wide range of funders
with approximately 50% coming from NIHR.
A total of 85% of responses indicated that the CRTF
had signiﬁcantly or very signiﬁcantly affected their com-
petence and achievements as a researcher and 94% that
it had signiﬁcantly or very signiﬁcantly affected their
career.
DISCUSSION
This is the ﬁrst analysis of outcome of clinical training
fellows in the UK and, accepting the pitfalls of any
questionnaire-based analysis, provides robust evidence of
the value of this capacity building mode of funding. We
have identiﬁed that this remains a major source of clin-
ical academics across the UK with the majority engaging
in research, education and wider administrative duties,
be they holding primarily University or NHS contracts.
This University–NHS synergy is exempliﬁed through the
cross-fertilisation of clinical and research activity within
the cohort, albeit with a different emphasis of research
activity (leading in the University sector, participating as
an NHS employee). Across universities it appears that
the CRTF scheme generates many Clinical Senior
Lecturers, Readers and Professors; up to 40% of any
year cohort is likely to be awarded a Professorship.
Importantly, many of these, exempliﬁed through
Fellowship of the Academy of Medical Sciences, are con-
ducting research to the highest level internationally and
are likely to be world leaders in their ﬁeld.
Despite the outstanding response from this survey,
there are however some limitations of any survey of this
nature. The 1991 cohort is restricted to information on
destinations only. The vast majority are likely to have
obtained PhD and/or MD higher degrees but this is not
conﬁrmed. Of the 191 respondents from the second
cohort 46 identiﬁed 2004 as the year their CRTF was
awarded but this cannot be true because the survey was
only dispatched to individuals starting their CRTF
between 1993 and 2003; undoubtedly some individuals
have responded as the year the degree was conferred
rather than the year their CRTF was awarded. Finally we
have no data on the MRC CRTF applicants who were
not successful at the interview.
We have focused on outcome data from an MRC
cohort, but have no reason to believe that these data
Figure 2 Outcome data of 191 MRC Clinical Research Training Fellowships commencing fellowships between 1993 and 2003.
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cannot be extrapolated to other UK CRTF schemes such
as those funded by the Wellcome Trust, British Heart
Foundation and other smaller charities such as Arthritis
Research UK. Each programme recruits candidates of
the highest calibre, through rigorous peer review and
interview, with overall application success rates of
10–15%. In recent years, the MRC has administered the
CRTF process for a group of 21 smaller, cofunding char-
ities (e.g., Kidney Research UK) where the benchmark-
ing of candidate quality is valued by the partner charity.
The newer NIHR scheme has only been in place for
3 years and focuses more on supporting applied health
research. Longer-term outcome data are required to
evaluate this programme and related Charity funded
CRTF schemes.
Outcome data from related programmes internation-
ally is scant, not least because of lack of obvious compara-
tive schemes. Several reports document outcomes from
combined MD–PhD programmes showing overall success
in tracking of this cohort to a predominantly research-
focused career.2–4 The US Physician–Scientist Training
programmes are perhaps the closest analogy to the MRC
CRTF, supported by the NIH since 2002 with the aim of
revitalising the clinical researcher pipeline.5 It is still early
days, but outcome data have already shown increased
competitiveness in attracting research funding.6
It appears that the MRC CRTF scheme has helped to
capacity build a cohort of clinical academics across the UK
embedded in research and education, 40% of whom
progress to a professorship and 20% of the 1991 cohort
have been awarded Fellowship of the Academy of
Medical Sciences, which is a widely accepted marker of
International research excellence. The recent Elsevier
report of the UK research landscape (http://www.bis.gov.
uk/assets/biscore/science/docs/i/11-p123-international-
comparative-performance-uk-research-base-2011.pdf )
places the UK second only to the USA in terms of its
and world-leading Biomedical research base. Importantly,
within the NHS, the CRTF scheme is providing a man-
power ‘research engine’ for the UK to undertake clinical
research and engage with pharmaceutical industry at a
time when the UK government is looking to Medicine to
generate economic growth (http://www.bis.gov.uk/assets/
biscore/innovation/docs/s/11–1429-strategy-for-uk-life-
sciences.pdf).
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